These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 23848392
1. Mean corpuscular volume is associated with endothelial dysfunction and predicts composite cardiovascular events in patients with chronic kidney disease. Solak Y, Yilmaz MI, Saglam M, Demirbas S, Verim S, Unal HU, Gaipov A, Oguz Y, Kayrak M, Caglar K, Vural A, Turk S, Covic A, Kanbay M. Nephrology (Carlton); 2013 Nov; 18(11):728-35. PubMed ID: 23848392 [Abstract] [Full Text] [Related]
2. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, Cetinkaya H, Eyileten T, Acikel C, Vural A, Covic A. Am J Nephrol; 2012 Nov; 36(3):228-37. PubMed ID: 22948239 [Abstract] [Full Text] [Related]
3. The relationship between IL-10 levels and cardiovascular events in patients with CKD. Yilmaz MI, Solak Y, Saglam M, Cayci T, Acikel C, Unal HU, Eyileten T, Oguz Y, Sari S, Carrero JJ, Stenvinkel P, Covic A, Kanbay M. Clin J Am Soc Nephrol; 2014 Jul; 9(7):1207-16. PubMed ID: 24789549 [Abstract] [Full Text] [Related]
4. Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes. Yilmaz MI, Stenvinkel P, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Çakar M, Altun B, Yenicesu M, Carrero JJ. Nephrol Dial Transplant; 2011 Nov; 26(11):3537-43. PubMed ID: 21378154 [Abstract] [Full Text] [Related]
5. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients. Kanbay M, Siriopol D, Saglam M, Kurt YG, Gok M, Cetinkaya H, Karaman M, Unal HU, Oguz Y, Sari S, Eyileten T, Goldsmith D, Vural A, Veisa G, Covic A, Yilmaz MI. J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883 [Abstract] [Full Text] [Related]
6. Red cell distribution width is independently related to endothelial dysfunction in patients with chronic kidney disease. Solak Y, Yilmaz MI, Saglam M, Caglar K, Verim S, Unal HU, Gok M, Demirkaya E, Gaipov A, Kayrak M, Cetinkaya H, Eyileten T, Turk S, Vural A. Am J Med Sci; 2014 Feb; 347(2):118-24. PubMed ID: 23928544 [Abstract] [Full Text] [Related]
7. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients. Tabata N, Hokimoto S, Akasaka T, Arima Y, Sakamoto K, Yamamoto E, Tsujita K, Izumiya Y, Yamamuro M, Kojima S, Kaikita K, Ogawa H. Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597 [Abstract] [Full Text] [Related]
8. Serum uric acid independently predicts cardiovascular events in advanced nephropathy. Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E, Unal HU, Arslan E, Verim S, Madero M, Caglar K, Oguz Y, McFann K, Johnson RJ. Am J Nephrol; 2012 Jul; 36(4):324-31. PubMed ID: 23007099 [Abstract] [Full Text] [Related]
9. IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival. Gungor O, Unal HU, Guclu A, Gezer M, Eyileten T, Guzel FB, Altunoren O, Erken E, Oguz Y, Kocyigit I, Yilmaz MI. PLoS One; 2017 Jul; 12(6):e0178939. PubMed ID: 28614418 [Abstract] [Full Text] [Related]
10. Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events. Wang CP, Lu LF, Yu TH, Hung WC, Chiu CA, Chung FM, Hsu CC, Lu YC, Lee YJ, Houng JY. J Nephrol; 2013 Jul; 26(1):111-8. PubMed ID: 22460182 [Abstract] [Full Text] [Related]
11. Thyroid function and cardiovascular events in chronic kidney disease patients. Afsar B, Yilmaz MI, Siriopol D, Unal HU, Saglam M, Karaman M, Gezer M, Sonmez A, Eyileten T, Aydin I, Hamcan S, Oguz Y, Covic A, Kanbay M. J Nephrol; 2017 Apr; 30(2):235-242. PubMed ID: 27039198 [Abstract] [Full Text] [Related]
12. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease. Perkins RM, Kirchner HL, Hartle JE, Bucaloiu ID. Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165 [Abstract] [Full Text] [Related]
13. Assessment of endothelial dysfunction in Asian Indian patients with chronic kidney disease and changes following renal transplantation. Sharma J, Kapoor A, Muthu R, Prasad N, Sinha A, Khanna R, Kumar S, Garg N, Tewari S, Sharma RK, Goel P. Clin Transplant; 2014 Aug; 28(8):889-96. PubMed ID: 24930933 [Abstract] [Full Text] [Related]
14. The significance of micro- and macrovascular biomarkers on cardiovascular outcome in chronic kidney disease: a prospective cohort study. Cseprekál O, Egresits J, Tabák Á, Nemcsik J, Járai Z, Babos L, Fodor E, Farkas K, Godina G, Kárpáthi KI, Kerkovits L, Marton A, Nemcsik-Bencze Z, Németh Z, Sallai L, Kiss I, Tislér A. J Hum Hypertens; 2016 Jul; 30(7):449-55. PubMed ID: 26424101 [Abstract] [Full Text] [Related]
15. Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease. Okada T, Nakao T, Matsumoto H, Nagaoka Y, Tomaru R, Iwasawa H, Wada T. Hypertens Res; 2009 Dec; 32(12):1123-9. PubMed ID: 19816503 [Abstract] [Full Text] [Related]